EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions

Mohamed J Saadh, Khadijehsadat Kazemi, Hossein Khorramdelazad, Mohammad Javad Mousavi, Negar Noroozi, Maryam Masoumi, Jafar Karami

International Immunopharmacology · 2023-06 · 119 · 110246

DOI: 10.1016/j.intimp.2023.110246 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-06. Verfasst von Mohamed J Saadh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, Faculty of Pharmacy, Middle East University, Amman, Jordan; Applied Science Private University, Amman, Jordan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Skin Diseases, Autoimmune Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 170 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence demonstrates that T cells are implicated in developing SLE, and each of them dominantly uses distinct metabolic pathways. Indeed, intracellular enzymes and availability of specific nutrients orchestrate fate of T cells and lead to differentiation of regulatory T cells (Treg), memory T cells, helper T cells, and effector T cells. The function of T cells in inflammatory and autoimmune responses is determined by metabolic processes and activity of their enzymes. Several studies were conducted to determine metabolic abnormalities in SLE patients and clarify how these modifications could control the functions of the involved T cells. Metabolic pathways such as glycolysis, mitochondrial pathways, oxidative stress, mTOR pathway, fatty acid and amino acid metabolisms are dysregulated in SLE T cells. Moreover, immunosuppressive drugs used in treating autoimmune diseases, including SLE, could affect immunometabolism. Developing drugs to regulate autoreactive T cell metabolism could be a promising therapeutic approach for SLE treatment. Accordingly, increased knowledge about metabolic processes paves the way to understanding SLE pathogenesis better and introduces novel therapeutic options for SLE treatment. Although monotherapy with metabolic pathways modulators might not be sufficient to prevent autoimmune disease, they may be an ideal adjuvant to reduce administration doses of immunosuppressive drugs, thus reducing drug-associated adverse effects. This review summarized emerging data about T cells that are involved in SLE pathogenesis, focusing on immunometabolism dysregulation and how these modifications could affect the disease development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicSkin DiseasesAutoimmune DiseasesHumansT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryOxidative StressImmunosuppressive Agents

Stichwörter der Autor:innen

AutoimmunityImmunometabolismSLE T cellSystemic lupus erythematous

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Basic Sciences, Faculty of Pharmacy, Middle East University, Amman, Jordan; Applied Science Private University, Amman, Jordan.
  • Faculty of Nursing, Golestan University of Medical Sciences, Golestan, Iran.
  • Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Hematology, School of Para-Medicine, Bushehr University of Medical Sciences, Bushehr, Iran; Student Research and Technology Committee, Bushehr University of Medical Sciences, Bushehr, Iran.
  • Student Research and Technology Committee, Bushehr University of Medical Sciences, Bushehr, Iran.
  • Clinical Research Development Center, Shahid Beheshti Hospital, Qom University of Medical Sciences, Qom, Iran. Electronic address: m.masoumiy@gmail.com.

Zitieren

APA

Saadh, M. J., Kazemi, K., Khorramdelazad, H., Mousavi, M. J., Noroozi, N., Masoumi, M., & Karami, J. (2023). Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions. International Immunopharmacology, 119, 110246. https://doi.org/10.1016/j.intimp.2023.110246

Vancouver

Saadh MJ, Kazemi K, Khorramdelazad H, Mousavi MJ, Noroozi N, Masoumi M, et al. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions. International Immunopharmacology. 2023;119:110246. doi:10.1016/j.intimp.2023.110246

BibTeX
@article{Saadh2023,
  author = {Saadh, Mohamed J and Kazemi, Khadijehsadat and Khorramdelazad, Hossein and Mousavi, Mohammad Javad and Noroozi, Negar and Masoumi, Maryam and Karami, Jafar},
  title = {Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {119},
  pages = {110246},
  doi = {10.1016/j.intimp.2023.110246}
}
Kostenlos starten →